Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Valeant's subsidiary Biovail acquires Canadian rights to Cholestagel from Genzyme
Valeant's subsidiary Biovail acquires Canadian rights to Cholestagel from Genzyme
Valeant's subsidiary Biovail acquires Canadian rights to Cholestagel from Genzyme
Submitted by
admin
on February 12, 2011 - 2:26pm
Source:
pharmabiz
News Tags:
Biovail
Genzyme
Cholestagel
hypercholesterolemia
colesevelam
Headline:
Valeant's subsidiary Biovail acquires Canadian rights to Cholestagel from Genzyme
Do Not Allow Advertisers to Use My Personal information
